Back to top

messenger-rna: Archive

Zacks Equity Research

MRNA Seeks FDA Nod for Updated COVID-19 Vaccine

Moderna files with FDA for updated Spikevax aimed at the LP.8.1 variant, which makes up 70% of U.S. COVID-19 cases.

PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change BNTXPositive Net Change

Zacks Equity Research

MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot

Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on the experimental flu shot.

SNYNegative Net Change PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change